0001574774-18-000048.txt : 20180725
0001574774-18-000048.hdr.sgml : 20180725
20180725185306
ACCESSION NUMBER: 0001574774-18-000048
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180723
FILED AS OF DATE: 20180725
DATE AS OF CHANGE: 20180725
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GORMAN KIRK E
CENTRAL INDEX KEY: 0001181032
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55039
FILM NUMBER: 18969652
MAIL ADDRESS:
STREET 1: 367 SOUTH GULPH ROAD
CITY: KING PRUSSIA
STATE: PA
ZIP: 19406
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOTELEMETRY, INC.
CENTRAL INDEX KEY: 0001574774
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 462568498
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 CEDAR HOLLOW ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 610-729-7000
MAIL ADDRESS:
STREET 1: 1000 CEDAR HOLLOW ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
FORMER COMPANY:
FORMER CONFORMED NAME: BioTelemetry, Inc.
DATE OF NAME CHANGE: 20130418
4
1
wf-form4_153255917122191.xml
FORM 4
X0306
4
2018-07-23
0
0001574774
BIOTELEMETRY, INC.
BEAT
0001181032
GORMAN KIRK E
1000 CEDAR HOLLOW RD. SUITE 102
MALVERN
PA
19355
1
0
0
0
Common Stock
2018-07-23
4
M
0
7500
30.98
A
180815
D
Common Stock
2018-07-23
4
S
0
7500
50.74
D
173315
D
Stock Options (Right to Buy)
30.98
2018-07-23
4
M
0
7500
0
D
2018-08-18
Common Stock
7500.0
0
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $50.20 to $51.00, inclusive. The reporting person undertakes to provide to BioTelemetry, Inc., any security holder of BioTelemetry, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The options were fully exercisable on the third anniversary of the date of grant.
/s/ Peter F. Ferola, Attorney-in-Fact
2018-07-25